Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOX CORD 1K in complex diabetic foot ulcers
NCT03296436Phase 1Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Tissue Cells
01
Overview
Phase 1, open-label, single-arm trial of TTAX01 in diabetic foot ulcer (DFU), sponsored by Johns Hopkins University. Primary endpoint: Complete ulcer closure at 16 weeks. Planned start Jan 2020; status: withdrawn.
02
Drugs
TTAX01
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03296436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03296436.